University of Rochester Newsroom
New Long-term Data Demonstrate Patients with Mild Heart Failure Sustained ...
PR Newswire (press release)
NATICK, Mass., March 30, 2014 /PRNewswire/ -- In the longest follow-up to date of cardiac resynchronization therapy (CRT) for mild heart failure patients, Boston Scientific Corporation's (NYSE: BSX) exclusively sponsored and landmark Multicenter ...
Device Saves Lives in Heart Failure Patients
Sheba Medical Center team heads important heart failure research
Survival Benefit Found After Long-Term Resynchronization Therapy